Icy head keeps Japanese beer cold
IOL Business - Jun 6th 2012, 08:03
While Japan struggles to generate enough electricity to keep air conditioners humming through its steamy summer, brewer Kirin is offering relief â€“ a pint of ice cold draft beer topped with frozen froth.
A machine similar to those used to make frozen yogurt freezes the head of the beer into something that looks like a soft serve ice cream, helping to keep pints frosty cold even as the mercury tops 40ÂşC.
Made of pure beer, the frozen froth keeps the beer chilled for at least 30 minutes, well over the average of 22 minutes to finish a pint, as a Kirin survey found.
Kunihiko Kadota, Kirinâ€™s marketing brand manager said: â€śWomen and young drinkers spend much more time to drink it all up, and they like the idea the beer doesnâ€™t get warm towards the end.â€ť â€“ Reuters
Adcock gets proposals for 100% aquisition
10/05/2013 - 08:05
South African drugmaker Adcock Ingram said on Thursday a rival bid was in the offing to a $675m (R60.7) one made by conglomerate Bidvest [JSE:BVT], raising the stakes for a possible acquisition and pushing its share price up almost 8%.
US: Berghoff Brewing to revive brands, change brewers
24/04/2013 - 07:53
Berghoff Brewing will revive its brands this summer with updated recipes, and a move to contract brewing the beers at Stevens Point Brewery.
Namibian pharmaceutical manufacturer, Fabupharm, grows 100% in one year
23/04/2013 - 09:51
Fabupharm Products, a wholly-owned Namibian pharmaceutical manufacturer, has doubled in size over the past year. Subsequent to upgrading its manufacturing facility to comply with international standards, Fabupharm announced recently it has received an Official Manufacturing GMP (Good Manufacturing Practice) License from the Namibian Medicines Regulatory Council (NMRC). This means that Fabupharm is now licensed to manufacture scheduled medicinal products.
Aspen to buy Nestle infant food business
18/04/2013 - 13:25
Johannesburg - Aspen Pharmacare Holdings [JSE:APN] has plans to buy Nestle's infant nutritional business for $215m, the company said on Thursday.
US: Johnson & Johnson tops estimates as prescription, OTC drugs shine
18/04/2013 - 11:21
(Reuters) - Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had been recalled over quality control problems.